View Clinical Trial (Medical Research Study)
Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder - NCT00996164-(Clinical Trial 369592)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Tacoma |
|
State:
|
|
WA |
| Zip Code: |
|
|
| Conditions: |
|
Sexual Dysfunctions, Psychological |
| Purpose: |
|
The object of this trial is to assess the safety and efficacy of a 24 week course of
flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. Premenopausal women who are 18 years old and older
2. Primary diagnosis of hypoactive sexual desire disorder, generalized acquired type
according to Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition,
Text Revision, at least 24 weeks in duration.
3. Stable, monogamous heterosexual relationship for at least one year.
4. Willing to discuss sexual issues.
5. Willing to engage in sexual activity at least once a month
6. Normal pap smear
7. Must use medically acceptable method of contraception
8. Able to comply with daily use of a handheld entry device
Exclusion Criteria:
1. Patients who have taken any medication in the protocol List of Prohibited Medications
within 30 days before the screening visit.
2. Patients who meet Diagnostic and Statistical Manual of Mental Disorder, Fourth
Edition, Text Revision for: Sexual aversion disorder, substance induced sexual
dysfunction, Dyspareunia, vaginismus, gender identity disorder, paraphilia, sexual
dysfunction do to a general medical condition.
3. Partner with inadequately treated organic or psychosexual dysfunction
4. History of Major Depressive Disorder within six months prior to the screening visit
or history of suicidal behavior.
5. Sexual function impaired by psychiatric disorder
6. Sexual function impaired by gynecological disorder
7. Major life stress that could impair sexual function
8. Substance abuse |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 12, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|